CLINICAL ENCOUNTERS
ANTICOAGULATION
| Question 
 [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
 | 
 what are the risks of VKAs? 
|  |  hemorrhage due to underdosage 
 | 
|  |  bleeding due to overdose 
 | 
|  |  underdose-related thrombosis 
 | 
|  |  overdose-related thrombosis 
 | 
 Explanation: 
Detailed explanation-1: -Limitations of VKAs include: Narrow therapeutic window. Interactions with drugs and food (e.g. foods rich in vitamin K) Delayed onset and offset of anticoagulant effect (this is a particular limitation for prevention of venous thromboembolism, in which the duration of therapy is relatively short)
Detailed explanation-2: -One part related to bleeding signs and management of bleeding or nonbleeding patients with a high INR: For all patients, signs of hemorrhage and internal bleeding were indicated such as epistaxis, gastrointestinal bleeding, intracranial hemorrhage, hematuria, melena, hematoma, palpitations, syncope, or fatigue.
 There is 1 question to complete.